Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine and acetylcholine in selective attention and working memory
2009-011093-15Phase 2Completed
- Sponsor
- Otto von Guericke University Magdeburg
- Start
- Sep 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Levodopa crossover arm with Galantamine crossover arm (2 arms). Primary endpoint: Memory and attention performance. Started Sep 2009; status: completed.
02
Drugs
levodopagalantamine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2009-011093-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011093-15.